ArticleFrontiers in oncology2021

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma.

Qiyu Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.